Top Markets
Coin of the day
YanAn Bicon Pharmaceutical Listed Company YanAn Bicon Pharmaceutical Listed Company

YanAn Bicon Pharmaceutical Listed Company

002411
Rang in Aktien #20199
YanAn Bicon Pharmaceutical Listed Company operates as a Chinese entity focused... YanAn Bicon Pharmaceutical Listed Company operates as a Chinese entity focused on the entire lifecycle—from research and development to production and distribution—of pharmaceutical intermediates, pesticide intermediates, and advanced energy and materials products. Its product portfolio features medical goods sold under the "Bikangweizheng" and "DoctorBaby" brand names. The company's product offerings include lithium hexafluorophosphate, a key constituent for lithium-ion battery electrolytes. Beyond this, it manufactures and supplies various high-performance composite materials. These composite materials are integral to numerous applications, including but not limited to cut-resistant gloves, home textile items, cables, fishing nets, outdoor sportswear, bulletproof helmets, stab-resistant clothing, as well as components for military and aerospace industries, ocean-going vessels, naval ship ropes, deep-sea fishing trawls, anti-wind wave cages, sporting equipment, and construction engineering reinforcement. Among its pharmaceutical intermediates are triclopyridine sodium, 5,5-dimethylhydantoin, and benzaldehyde. Established in 2007 and headquartered in Xi'an, China, the company underwent a name change in October 2018. Previously known as JiangSu Bicon Pharmaceutical Listed Company, it adopted its current designation, YanAn Bicon Pharmaceutical Listed Company. It was formerly an affiliate of Xinyi Bicon New Medicine Industry Complex Investment Co., Ltd.
Aktienkurs
$0.08984661
Zuletzt synchronisiert: 2023-07-11
Marktkapitalisierung
$137.67M
Veränderung (1 Tag)
-5.84%
Veränderung (1 Jahr)
0.00%
Land
CN
Handel YanAn Bicon Pharmaceutical Listed Company (002411)
Operative Marge für YanAn Bicon Pharmaceutical Listed Company (002411)
Operative Marge zum 2026 TTM: 0.00%
Laut den neuesten Finanzberichten und dem Aktienkurs von YanAn Bicon Pharmaceutical Listed Company beträgt die aktuelle operative Marge (TTM) 0.00%. Am Ende des Jahres 2026 lag die operative Marge bei 0.00%.
Historie der operativen Marge von YanAn Bicon Pharmaceutical Listed Company von 2026 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
Nicht genügend Daten für die angegebenen Daten.
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
25.56% -
JP
0.00% -
DE
6.22% -
TW
5.98% -
SA
-0.42% -
CN
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.